IP Library Granted Patent US 8,716,024
Granted Patent B2
US 8,716,024 · App. 13/682,380 · Granted May 6, 2014

Control solution for use in testing an electrochemical system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,716,024
App. No.
13/682,380
Granted
May 6, 2014
Kind
B2
Abstract

A method of distinguishing a control solution from a sample in an electrochemical test sensor is performed. The method includes adding a control marker to the control solution. The control solution includes the control marker and analyte. The test sensor includes working and counter electrodes, and a reagent. A potential is applied to the test sensor to oxidize the control marker and the analyte. The resulting electrical current is measured. A potential is applied to the test sensor lower than the other potential in which the potential is sufficient to oxidize the analyte and not the control marker. The resulting electrical current is measured. Determining whether a control solution or a sample is present based on the measured electrical currents. To increase the measured current, a salt may be added to the control solution in an amount sufficient to increase the electrical current by at least 5% as compared to a control solution in the absence of a salt.

Claims (7)

1. A control solution for use in an electrochemical system, the control solution comprising:

(a) an amount of an analyte; and

(b) an amount of a control marker, the control marker being adapted to be oxidized at a potential higher than the potential required to oxidize the analyte, the control marker being selected from the group consisting of: 3-[4-(hydroxyphenyl)amino]-3-oxopropanoic acid, 2-napthylamine 1-sulfonic acid, sodium diphenylamine-4-sulfonate, and salts thereof, the amount of the control marker being related to the amount of analyte such that the presence of the control marker is detectable.

2. The control solution of claim 1 wherein the control marker is sodium diphenylamine-4-sulfonate.

3. The control solution of claim 1 wherein the analyte is glucose.

4. The control solution of claim 1 wherein the control marker is 3-[4-(hydroxyphenyl)amino]-3-oxopropanoic acid or salts thereof.

5. The control solution of claim 1 wherein the control marker is 2-napthylamine 1-sulfonic acid or salts thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2016
From: BAYER HEALTHCARE LLC
To: ASCENSIA DIABETES CARE HOLDINGS AG
Reel/Frame 037880/0604 →
CORRECTIVE ASSIGNMENT TO CORRECT THE TYPOGRAPHICAL ERROR IN LOCATION WHERE BAYER HEALTHCARE LLC IS ORGANIZED & EXISTING. CORRECT STATE IS DELAWARE; NOT NEW YORK. PREVIOUSLY RECORDED ON REEL 029633 FRAME 0638. ASSIGNOR(S) HEREBY CONFIRMS THE LOCATION OF BAYER HEALTHCARE LLC BEING ORGANIZED AND EXISTING IN THE STATE OF DELAWARE.. Recorded Dec 21, 2015
From: TSAI, FU HSIUNG; WU, HUAN-PING; ELLIS, NICOLE D.; ARNDT, HENRY C.; LIN, JING
To: BAYER HEALTHCARE LLC
Reel/Frame 037358/0209 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2013
From: LIN, JING; TSAI, FU HSIUNG; WU, HUAN-PING; ELLIS, NICOLE D.; ARNDT, HENRY C.
To: BAYER HEALTHCARE LLC
Reel/Frame 029633/0638 →